(Q22252209)

PubMed

PubMed publication ID

23369588

8 February 2023

Adam Ingraffea

series ordinal

author given names

Adam

author last names

Ingraffea

1 reference

PubMed

PubMed publication ID

23369588

Facial plastic surgery clinics of North America

8 February 2023

language of work or name

English

0 references

publication date

February 2013

0 references

published in

1 reference

0 references

0 references

43-53

0 references

cites work

Sentinel lymph node biopsy for evaluation and treatment of patients with Merkel cell carcinoma: The Dana-Farber experience and meta-analysis of the literature

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

Adjuvant local irradiation for Merkel cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

EPIDERMOTROPIC ECCRINE CARCINOMA. A CASE COMBINING FEATURES OF ECCRINE POROMA AND PAGET'S DERMATOSIS

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

Incidence estimate of nonmelanoma skin cancer in the United States, 2006.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

Immunohistochemical distinction of ocular sebaceous carcinoma from basal cell and squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

Sebaceous gland carcinoma. Review of 40 cases

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

Atypical fibroxanthoma of the skin. A clinicopathologic study of 140 cases

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

Microcystic adnexal carcinoma: a distinct clinicopathologic entity

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

Adnexal carcinomas of the skin. II. Extraocular sebaceous carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

Actinic keratoses: Natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

Carcinoma of the skin of the head and neck with perineural invasion

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

A histopathological and ultrastructural study of eccrine porocarcinoma with special reference to its subtypes

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

1 reference

7 January 2021

The role of radiation therapy in the management of skin cancers

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

Microcystic adnexal carcinoma: treatment with Mohs micrographic surgery

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

Basal cell carcinoma treated with Mohs surgery in Australia II. Outcome at 5-year follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

Imiquimod 5% cream monotherapy for cutaneous squamous cell carcinoma in situ (Bowen's disease): A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

A relative value unit-based cost comparison of treatment modalities for nonmelanoma skin cancer: effect of the loss of the Mohs multiple surgery reduction exemption

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

Sebaceous carcinoma of the eyelids: personal experience with 60 cases

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

Epidermal growth factor receptor (EGFR) and squamous cell carcinoma of the skin: molecular bases for EGFR-targeted therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

Merkel cell carcinoma: update and review

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

Sebaceous carcinomas of the ocular adnexa: A clinicopathologic study of 104 cases, with five-year follow-up data

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

Merkel cell carcinoma and HIV infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

Non-melanoma skin cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

Treatment options and future prospects for the management of eyelid malignancies: an evidence-based update

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

Widespread metastatic eccrine porocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

Microcystic adnexal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

Eccrine porocarcinoma. Report of nine cases

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

Activating Smoothened mutations in sporadic basal-cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

Identification of the cell lineage at the origin of basal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

Accuracy of the clinical diagnosis of chalazion

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

Merkel cell carcinoma: more deaths but still no pathway to blame

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

The epidemiology of skin cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

Why classify basal cell carcinomas?

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

Eccrine porocarcinoma treated with Mohs micrographic surgery: A report of five cases

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

Prognostic factors for metastasis in squamous cell carcinoma of the skin

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

Sebaceous carcinoma of the eyelids treated by mohs micrographic surgery: report of nine cases with review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

1 reference

7 January 2021

Epidemiology of actinic keratoses and squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

Sebaceous carcinoma of the eyelid treated with Mohs micrographic surgery

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

Risk factors for skin cancers: a nested case-control study within the Nurses' Health Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

Neuroendocrine (Merkel cell) carcinoma of the skin. Its natural history, diagnosis, and treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

Immunohistochemical distinction between merkel cell carcinoma and small cell carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

Merkel cell polyomavirus expression in merkel cell carcinomas and its absence in combined tumors and pulmonary neuroendocrine carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

Hedgehog signaling in animal development: paradigms and principles

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

A case of porocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

Sebaceous carcinoma arising in nevus sebaceus

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

Eccrine poroma: two unusual variants

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

Three cases of eccrine porocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

Photodynamic therapy with topical methyl aminolaevulinate for 'difficult-to-treat' basal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

Skin cancer incidence and the ageing population

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

Does progression from actinic keratosis and Bowen's disease end with treatment: diclofenac 3% gel, an old drug in a new environment?

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

Two cases of Bowen's disease successfully treated topically with 3% diclofenac in 2.5% hyaluronan gel.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

PEP005 (ingenol mebutate) gel for the topical treatment of superficial basal cell carcinoma: results of a randomized phase IIa trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

A review of laser and photodynamic therapy for the treatment of nonmelanoma skin cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

Sebaceous carcinoma of the eyelid: a review of 14 cases

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

More than 2 decades of treating atypical fibroxanthoma at mayo clinic: what have we learned from 91 patients?

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

Eccrine porocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

Sebaceous carcinoma: the great masquerader: emgerging concepts in diagnosis and treatment.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

Eccrine porocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

Morphological and immunohistochemical characteristics of atypical fibroxanthoma with a special emphasis on potential diagnostic pitfalls: a review

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

Clonal integration of a polyomavirus in human Merkel cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

p53 mutations in human cancers

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

Sebaceous carcinoma of the eyelid: a clinicopathological study

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

Phase I trial of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with refractory, locally advanced or metastatic solid tumors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

Adjuvant radiation therapy is associated with improved survival in Merkel cell carcinoma of the skin

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

Merkel cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

Epidemiology of basal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

Photodynamic therapy in the treatment of cancer: current state of the art.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

Inhibition of cyclooxygenase: a novel approach to cancer prevention

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021

Merkel cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.FSC.2012.10.003

7 January 2021